The enlightenment of Japan's drug clinical trial insurance system under the marketing authorization holder system to ChinaZOU Yi-xuan, CHEN Yun, LIU Peng-cheng, ZHOU Bin, SHAO Rong369-372
Data analysis of the reference medical product record platform for generic drugs consistency evaluationXU Ming-di, GUAN Hao-yue, CUI Meng, GAO Tian-tian, SHI Li-wei, MA Ling-yun373-378
Patent information analysis of traditional Chinese medicine in ChinaFENG Xue-fei, YUAN Hong-mei379-384
Analysis of patent applications of the HCV inhibitor daclatasvir in ChinaJIANG Jun-hao, DENG Ping385-389
Consideration on clinical pharmacological studies of anti-PD-1 and anti-PD-L1 antibodiesLI Na, WANG Yu-zhu, YANG Jin-bo390-397
Network pharmacology mechanism study on the effective constituents of Polygala Tenuifolia for anti-Alzheimer's diseaseJIA Hao, PANG Xiao-cong, ZHAO Ying, WANG Hai-gang, LIU Ai-lin, DU Guan-hua398-404
Comparison of measurement methods of delivered-dose uniformity of salbutamol sulfate inhalation aerosolWEI Ning-yi, ZHOU Ying, CHEN Cui-cui, LIN Lan, NING Bao-ming405-408
Progress in researches of patient-centric individualized formulation approachesCHU Xiao-yang, GAO Chun-hong, GE Cheng, GAO Chun-sheng409-416
Recent progress of SGLT2 inhibitors in metabolic regulationWEN Xiao-hua, JU Lin-jie, WANG Chun-jun, WANG Jia-li, SHU Luan417-421
Review on chemical constituents of phenanthrenes from plants of Pholidota genusHU Jun, GUO Jie, YAN He-gui, FU Xue-mei, LU An-mei, QIN Ze-min, YANG Ming-hui422-428